← Back to Screener
Telix Pharmaceuticals Limited American Depositary Shares (TLX)
Price$10.73
Favorite Metrics
Price vs S&P 500 (26W)3.48%
Price vs S&P 500 (4W)13.25%
All Metrics
Price vs S&P 500 (YTD)39.25%
10-Day Avg Trading Volume0.28M
3-Month Avg Trading Volume0.24M
52-Week Price Return-35.07%
52-Week High$20.00
26-Week Price Return12.23%
13-Week Price Return40.94%
3-Month Return Std Dev69.47%
Price vs S&P 500 (52W)-70.16%
Year-to-Date Return43.39%
5-Day Price Return-4.45%
Month-to-Date Return12.23%
Price vs S&P 500 (13W)38.08%
52-Week Low$6.28
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
TLXTelix Pharmaceuticals Limited American Depositary Shares | — | — | — | — | $10.73 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Telix develops radiopharmaceuticals, which combine radioisotopes with targeted molecules to diagnose and treat cancers. The company generates revenue from U.S. sales of Illuccix, a prostate cancer imaging agent, while advancing additional radiopharmaceutical candidates through its pipeline.